#615957
Table of Contents
A number sign (#) is used with this entry because spinocerebellar ataxia-38 (SCA38) is caused by heterozygous mutation in the ELOVL5 gene (611805) on chromosome 6p12.
Spinocerebellar ataxia-38 (SCA38) is an autosomal dominant neurologic disorder characterized by adult-onset of slowly progressive gait ataxia accompanied by nystagmus. Brain MRI shows cerebellar atrophy (summary by Di Gregorio et al., 2014).
For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).
Di Gregorio et al. (2014) reported 4 unrelated families, 3 Italian and 1 French, with a relatively pure form of autosomal dominant spinocerebellar ataxia. Patients presented with walking difficulties due to gait ataxia between 34 and 51 years of age. Additional features included nystagmus, slow saccades, dysarthria, and limb ataxia. The disorder was slowly progressive. Several patients had distal sensory impairment consistent with axonal neuropathy. Cognition was preserved.
The transmission pattern of SCA38 in the families reported by Di Gregorio et al. (2014) was consistent with autosomal dominant inheritance.
By genomewide linkage analysis of a large Italian family with autosomal dominant SCA, Di Gregorio et al. (2014) found linkage to a 56.2-Mb interval on chromosome 6p22.2-q14.1 between markers D6S276 and D6S460 (Zmax of 3.08).
In affected members of a large Italian family with autosomal dominant SCA38, Di Gregorio et al. (2014) identified a heterozygous missense mutation in the ELOVL5 gene (G230V; 611805.0001). The mutation was found by linkage analysis and candidate gene sequencing. Screening of the ELOVL5 gene in 456 European probands with SCA identified heterozygous mutations in 3 additional families (611805.0001 and 611805.0002). Arachidonic acid and docosahexaenoic acid, 2 final products of the enzyme, were reduced in the serum of affected individuals. Transfection of the mutations into several cell lines showed that the mutant proteins had a less diffuse ER signal compared to wildtype, and tended to accumulate in the Golgi apparatus. Transfected cells showed increased levels of CHOP (DDIT3; 126337), suggesting activation of the unfolded protein response that could lead to apoptosis.
In a French man with SCA38, Di Gregorio et al. (2014) identified a heterozygous missense mutation (L72V; 611805.0002) in the ELOVL5 gene.
Di Gregorio et al. (2014) identified the same ELOVL5 mutation (G230V; 611805.0001) in affected members of 3 unrelated Italian families with SCA38. Haplotype analysis indicated a founder effect.
Di Gregorio, E., Borroni, B., Giorgio, E., Lacerenza, D., Ferrero, M., Lo Buono, N., Ragusa, N., Mancini, C., Gaussen, M., Calcia, A., Mitro, N., Hoxha, E., and 23 others. ELOVL5 mutations cause spinocerebellar ataxia 38. Am. J. Hum. Genet. 95: 209-217, 2014. [PubMed: 25065913, images, related citations] [Full Text]
SNOMEDCT: 734021001; ORPHA: 423296; DO: 0050985;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 6p12.1 | Spinocerebellar ataxia 38 | 615957 | Autosomal dominant | 3 | ELOVL5 | 611805 |
A number sign (#) is used with this entry because spinocerebellar ataxia-38 (SCA38) is caused by heterozygous mutation in the ELOVL5 gene (611805) on chromosome 6p12.
Spinocerebellar ataxia-38 (SCA38) is an autosomal dominant neurologic disorder characterized by adult-onset of slowly progressive gait ataxia accompanied by nystagmus. Brain MRI shows cerebellar atrophy (summary by Di Gregorio et al., 2014).
For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).
Di Gregorio et al. (2014) reported 4 unrelated families, 3 Italian and 1 French, with a relatively pure form of autosomal dominant spinocerebellar ataxia. Patients presented with walking difficulties due to gait ataxia between 34 and 51 years of age. Additional features included nystagmus, slow saccades, dysarthria, and limb ataxia. The disorder was slowly progressive. Several patients had distal sensory impairment consistent with axonal neuropathy. Cognition was preserved.
The transmission pattern of SCA38 in the families reported by Di Gregorio et al. (2014) was consistent with autosomal dominant inheritance.
By genomewide linkage analysis of a large Italian family with autosomal dominant SCA, Di Gregorio et al. (2014) found linkage to a 56.2-Mb interval on chromosome 6p22.2-q14.1 between markers D6S276 and D6S460 (Zmax of 3.08).
In affected members of a large Italian family with autosomal dominant SCA38, Di Gregorio et al. (2014) identified a heterozygous missense mutation in the ELOVL5 gene (G230V; 611805.0001). The mutation was found by linkage analysis and candidate gene sequencing. Screening of the ELOVL5 gene in 456 European probands with SCA identified heterozygous mutations in 3 additional families (611805.0001 and 611805.0002). Arachidonic acid and docosahexaenoic acid, 2 final products of the enzyme, were reduced in the serum of affected individuals. Transfection of the mutations into several cell lines showed that the mutant proteins had a less diffuse ER signal compared to wildtype, and tended to accumulate in the Golgi apparatus. Transfected cells showed increased levels of CHOP (DDIT3; 126337), suggesting activation of the unfolded protein response that could lead to apoptosis.
In a French man with SCA38, Di Gregorio et al. (2014) identified a heterozygous missense mutation (L72V; 611805.0002) in the ELOVL5 gene.
Di Gregorio et al. (2014) identified the same ELOVL5 mutation (G230V; 611805.0001) in affected members of 3 unrelated Italian families with SCA38. Haplotype analysis indicated a founder effect.
Di Gregorio, E., Borroni, B., Giorgio, E., Lacerenza, D., Ferrero, M., Lo Buono, N., Ragusa, N., Mancini, C., Gaussen, M., Calcia, A., Mitro, N., Hoxha, E., and 23 others. ELOVL5 mutations cause spinocerebellar ataxia 38. Am. J. Hum. Genet. 95: 209-217, 2014. [PubMed: 25065913] [Full Text: https://doi.org/10.1016/j.ajhg.2014.07.001]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM